1
Dysport reduces muscle contractions by blocking the transmission of nerve impulses
Ipsen has announced the presentation of new study data on Dysport (abobotulinumtoxinA) in stroke and other neurological disorders. The data will be presented at the TOXINS 2026 conference in Madrid, Spain.
The company will present interim analysis from its ongoing EPITOME study. The study is evaluating adults from ages 18-85 following their first stroke in order to develop a clearer picture of the frequency of post-stroke spasticity (PSS), as well as to improve early identification of PSS. A Post-stroke…